All Posts: clinical trials
-
The Right Place, the Right Time, the Right People, Thanks to Cancer Center Collaboration
Category: GUMC Stories
-
Georgetown Technique Using Urine Suggests Individualized Bladder Cancer Treatment Possible
Category: News Release
-
Clinical Trial for Men With Osteoporosis Now Open for Volunteers
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (June 4, 2019) — Enrollment in a clinical trial testing a new treatment for men with osteoporosis is now open at Georgetown University Medical Center. Osteoporosis is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue (brittle bones) that makes bones more fragile and likely to […]
Category: News Release
-
Georgetown’s Memory Disorders Program Marks 20th Year
(April 12, 2019) — When President Ronald Reagan announced in 1994 that he had Alzheimer’s disease, the man known as the “great communicator” tried his best to convey a sense of optimism. “I now begin the journey that will lead me into the sunset of my life. I know that for America there will always […]
Category: GUMC Stories
-
Personalized Medicine Clinical Trial Underway for Type of Incontinence Common in Women
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (April 2, 2019) — A novel clinical trial aims to reverse the cause of a common problem among older women — accidental urine leakage — by using a patient’s own muscle cells. The study, now underway in the Washington area, is for women with stress urinary incontinence. Stress urinary incontinence, or […]
Category: News Release
-
A Commitment To Evidence Helps Merenstein Thrive As Physician-Scientist
(February 15, 2019) —As a tenured professor and the director of research programs in the department of family medicine at Georgetown University School of Medicine, Daniel Merenstein, MD, spends most of his time pursuing evidence-based answers to common clinical questions. A major focus of his research that epitomizes this quest involves probiotics — the so-called […]
Category: GUMC Stories
-
First Patient in a Clinical Trial Using Her Own Blood to Personalize Treatment for Non-Hodgkin Lymphoma Experiencing Remission
(January 11, 2019) — The first cancer patient to be treated as part of the CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center is now in “complete remission.” Daisy Diggs, 57, of Laurel, Md., volunteered for the experimental treatment after a lengthy battle with stage-three non-Hodgkin lymphoma, a type […]
Category: GUMC Stories
-
Lynce Receives Potter Award for Early Career Research
(November 21, 2018) — In the ten years since coming to the U.S. from Portugal to complete her medical training, Filipa Lynce, MD, has conducted clinical trials to establish safe and effective cancer treatments for minority patients, including African Americans and Latinas, and studied the genetic differences in cancers among patients of different ethnicities. Now a medical […]
Category: GUMC Stories
-
Precision Medicine and Immunotherapy: Tomorrow's Cancer Treatments Today at Georgetown Lombardi
Diane Lucey’s unusual cancer stumped her doctors. But after ordering a profile of her tumor, medical oncologist Louis Weiner knew exactly how to proceed.
Category: GUMC Stories
-
Georgetown Seeks Volunteers for New Immunotherapy Clinical Trial for Alzheimer’s
WASHINGTON — The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease. Georgetown is the only institution in the greater Washington, DC, area offering access to the phase 3 study of the investigational immunotherapy drug aducanumab.
Category: News Release